Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Stock Forecast

Stock Price Forecast

According to 13 professional analysts, the 12-month price target for Travere Therapeutics stock ranges from a low of $20 to a high of $47. The average analyst price target of $33.31 forecasts a 126.44% increase in the stock price over the next year.

Price Target: $33.31 (+126.44%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$33.31	$31	$47
Change	+35.96%	+126.44%	+110.74%	+219.51%

Analyst Ratings

The average analyst rating for Travere Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	4	4	4	4	5	5
Buy	6	6	8	8	7	7
Hold	3	2	1	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	12	13	13	13	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Laura Chico Wedbush	Wedbush	Buy Reiterates $30	Buy	Reiterates	$30	+103.94%	May 16, 2025
Laura Chico Wedbush	Wedbush	Buy Reiterates $30	Buy	Reiterates	$30	+103.94%	May 2, 2025
Alex Thompson Stifel	Stifel	Hold Maintains $22 → $23	Hold	Maintains	$22 → $23	+56.36%	May 2, 2025
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Apr 23, 2025
Vamil Divan Guggenheim	Guggenheim	Strong Buy Reiterates $47	Strong Buy	Reiterates	$47	+219.51%	Apr 14, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

406.68M

Increased by 74.41%

from 233.18M

Revenue Next Year

605.56M

Increased by 48.90%

from 406.68M

EPS This Year

-1.14

from -4.08

EPS Next Year

1.10

from -1.14

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	198.32M	131.84M	109.46M	145.24M	233.18M	406.68M	605.56M	741.33M
Revenue Growth	13.11%	-33.52%	-16.97%	32.69%	60.55%	74.41%	48.90%	22.42%
EPS	-3.56	-3.01	-4.37	-1.50	-4.08	-1.14	1.10	1.65
EPS Growth	-	-	-	-	-	-	-	50.23%
Forward PE	-	-	-	-	-	-	13.37	8.90
No. Analysts	-	-	-	-	-	17	16	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	472.3M	835.7M	823.8M
Avg	406.7M	605.6M	741.3M
Low	327.2M	441.2M	606.7M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	102.5%	105.5%	36.0%
Avg	74.4%	48.9%	22.4%
Low	40.3%	8.5%	0.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.53	3.47	2.58
Avg	-1.14	1.10	1.65
Low	-2.07	-0.96	0.31

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	134.8%
Avg	-	-	50.2%
Low	-	-	-71.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.